A
AREV Life Sciences Global Corp
CNSX:AREV
AREV Life Sciences Global Corp
CNSX:AREV
Price:
0.09
CAD
Market Cap:
CA$2.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
AREV Life Sciences Global Corp
CNSX:AREV
|
CA |
|
Rane Brake Linings Ltd
NSE:RBL
|
IN |
|
Naked Wines PLC
LSE:WINE
|
UK |
|
Isgec Heavy Engineering Ltd
NSE:ISGEC
|
IN |
|
S
|
Shenzhen Jove Enterprise Ltd
SZSE:300814
|
CN |
|
Kanabo Group PLC
LSE:KNB
|
UK |
|
Sandmartin International Holdings Ltd
HKEX:482
|
HK |
|
China Gold International Resources Corp Ltd
TSX:CGG
|
CA |
|
Mitre Realty Empreendimentos e Participacoes SA
BOVESPA:MTRE3
|
BR |
|
Kore Potash PLC
LSE:KP2
|
UK |
|
Viking Therapeutics Inc
NASDAQ:VKTX
|
US |
|
MDJM Ltd
NASDAQ:UOKA
|
UK |
|
B
|
Bekasi Fajar Industrial Estate Tbk PT
IDX:BEST
|
ID |
|
H
|
Herbal Dispatch Inc
CNSX:HERB
|
CA |
|
M
|
Medimaging Integrated Solution Inc
TWSE:6796
|
TW |
|
C
|
China Star Food Group Ltd
SGX:42W
|
SG |
|
Alexander & Baldwin Inc (Hawaii)
NYSE:ALEX
|
US |
|
P
|
P10 Inc
NYSE:PX
|
US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
US |
|
Formosa Plastics Corp
TWSE:1301
|
TW |
Balance Sheet
Balance Sheet Decomposition
AREV Life Sciences Global Corp
AREV Life Sciences Global Corp
Balance Sheet Decomposition is not available for
AREV Life Sciences Global Corp
AREV Life Sciences Global Corp
Balance Sheet
AREV Life Sciences Global Corp
AREV Life Sciences Global Corp
Currency: CAD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Current Assets |
1
|
1
|
0
|
1
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
1
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
1
-61%
|
1
+36%
|
1
+45%
|
1
-51%
|
0
-59%
|
|
| Liabilities | |||||||
| Accounts Payable |
0
|
0
|
0
|
1
|
1
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
2
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+2%
|
1
+97%
|
2
+37%
|
1
-63%
|
1
+68%
|
|
| Equity | |||||||
| Common Stock |
3
|
10
|
11
|
12
|
13
|
14
|
|
| Retained Earnings |
2
|
10
|
12
|
13
|
13
|
15
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
0
N/A
|
1
-704%
|
1
-22%
|
0
+85%
|
1
-919%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-61%
|
1
+36%
|
1
+45%
|
1
-51%
|
0
-59%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
4
|
8
|
9
|
20
|
27
|
32
|
|
Switch to:
Switch to:
See Also
Discover More
